Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction

NCT05335109 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Xenon
DRUG: Oxygen 30 %

Sponsor

Negovsky Reanimatology Research Institute